Printer Friendly

Articles from M2 Pharma (December 14, 2017)

1-31 out of 31 article(s)
Title Author Type Words
56% of US Consumers Don't Know Obamacare Open Enrollment Ends This Friday. 325
Ability obtains US FDA approval to proceed with phase 1/2a clinical trial of ABTL0812 for endometrial cancer or squamous non-small cell lung cancer. 301
Aprecia, Cycle Collaborate to Develop 3D-Printed Orphan Drugs. 283
Arrakis Therapeutics Licenses University of Pennsylvania for Access to RNA-targeted Small Molecule Technology. 213
Astellas names Anthony Fiordaliso as VP Americas Finance. 152
Astellas promotes Anthony Fiordaliso as new vice president, Americas Finance. 123
bluebird bio Prices USD 600m Public Common Stock Offering. 377
Bonesupport reports recruitment of 136 patients into the CERTiFy study. Clinical report 215
Bristol-Myers Squibb sBLA for Opdivo plus Yervoy in Cetain Renal Cell Carcinoma Patients Accepted for Review by US FDA. 287
CMC ICOS Biologics signs contract with Harpoon Therapeutics. 164
Complix awarded EUR0.5m grant to further develop proprietary Cell Penetrating Alphabodies. 214
Concert Pharmaceuticals to Join NASDAQ Biotechnology Index. 159
DURECT discloses US FDA's acceptance of RBP-7000 NDA for schizophrenia. 183
FDA Action Date for Xeljanz sNDA in Ulcerative Colitis Extended by Three Months. 263
Hovione admits first rosacea patient under MARS study of Minocycline Topical Gel. 252
IBBR awarded USD3.7m NIH grant to investigate body's T-cell mechanism of attack to fight tumors and viruses. 287
Kangen Pharmaceuticals Co acquires KC Specialty Therapeutics for undisclosed fee. 182
Millar Inc divests life sciences telemetry product line to Kaha Sciences. 176
Myonexus Therapeutics Secures USD 2.5m Seed Financing to Clinically Advance Limb-Girdle Muscular Dystrophy Gene Therapies. 484
Neumentum Raises USD 6m in Series A Funding to Develop Non-opioid Pain Products and Requests Type B Meeting with FDA. 449
NeuroVive reports on grant of orphan drug designation for KL1333 programme by European Commission. 223
Ono Pharmaceutical enters into licence agreement with Bristol-Myers Squibb. 193
PathoQuest and Mayo Clinic enter into research agreement. 223
Pierre Fabre Pharmaceuticals to Deploy IQVIA's Customer Engagement Solution. 302
Quartesian Inks Deal with Medidata to Expand Sponsor Access to the Medidata Clinical Cloud During Clinical Trials. 481
Repros Therapeutics signs contract with Allergan. 133
Results of Two Folotyn Studies Presented at ASH Annual Meeting. 344
Servier and Pfizer Trials of CAR T-cell Product Shows 83% Complete Remission Rate Across Adult and Pediatric B-ALL Patients. 447
Shire names new executive vice president, head of research and development, and CSO. 166
Shire receives marketing approval for new formulation of Oncaspar in Europe. 137
Survey Finds Insurance Companies are Forcing Massachusetts Patients Off Prescribed Medications. 361

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters